FFA
TNXP icon

Farther Finance Advisors’s Tonix Pharmaceuticals TNXP Stock Holding History

Farther Finance Advisors’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.85K Buy
302
+166
+122% +$2.14K ﹤0.01% 4924
2026
Q1 		$1.86K Sell
136
-12
-8% -$185 ﹤0.01% 4925
2025
Q4 		$2.31K Buy
+148
New +$2.73K ﹤0.01% 4641

Other funds holding TNXP

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
SIC
SJS Investment Consulting Sylvania, Ohio $919M AUM 23.4% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CNBT
Cornerstone National Bank & Trust Palatine, Illinois $296M AUM 12.13% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
WETS
Wealth Enhancement Trust Services Sioux Falls, South Dakota $900M AUM
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

Farther Finance Advisors's TNXP Position: Q2 2026 in Review

Farther Finance Advisors increased its Tonix Pharmaceuticals (TNXP) stake by 122% in Q2 2026, buying an estimated $2.14K and bringing the position to 302 shares worth $3.85K. The position accounts for ﹤0.01% of the portfolio, ranked #4924.

Farther Finance Advisors first reported a position in TNXP in Q4 2025 and has held it in 3 quarters since. 13 funds tracked by Wall St. Rank hold TNXP as of Q2 2026.

  • Farther Finance Advisors held 302 shares of Tonix Pharmaceuticals worth $3.85K as of Q2 2026.
  • Farther Finance Advisors bought 166 Tonix Pharmaceuticals shares in Q2 2026, an estimated $2.14K.
  • Tonix Pharmaceuticals made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #4924 holding.
  • Farther Finance Advisors first reported a position in Tonix Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 13 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.